The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis

Demir, Tamer; Gödekmerdan, Ahmet; Balbaba, Mehmet; Türkçüoglu, Peykan; Ilhan, Fulya; Demir, Nesrin; Gödekmerdan, Ahmet; Türkçüoglu, Peykan
December 2006
Indian Journal of Ophthalmology;Dec2006, Vol. 54 Issue 4, p241
Academic Journal
journal article
Background: To identify the effect of infliximab, cyclosporine A and recombinant IL-10 in experimental autoimmune uveitis.Materials and Methods: Sixty male rats were assigned to five groups of 12 each. All the groups (except the control group) were administered 30 microg retinal-S antigen intraperitoneally. On the 14th day, after confirmation of uveitis with histopathological study, daily cyclosporine A injection was given in cyclosporine A treatment group and physiological serum in the uveitis-induced placebo treatment and control groups. In the infliximab treatment group, infliximab was administered on the 14th, 15th, 17th, 19th and 21st days. In the recombinant IL-10 treatment group, three doses of recombinant IL-10 were given four hours and a half hours before and eight hours after retinal-S antigen administration. On the 21st day of the study, all rats were sacrificed and vitreous cytokine levels (IL-1, IL-6, IL-8 and TNF-alpha) were studied with ELISA.Results: In the treatment groups, cytokine levels (IL-1, IL-6 and TNF-alpha) were significantly lower than the uveitis-induced placebo treatment group. Compared with the control group, there was no significant difference with respect to TNF-alpha and IL-8 in the infliximab treatment group; IL-8 in the cyclosporine A treatment group; IL-6 and IL-8 in the recombinant IL-10 treatment group. The drugs used did not significantly differ in respect to their effects on vitreous IL-6, IL-8 and TNF-alpha levels.Conclusion: Cyclosporine A, infliximab and recombinant IL-10 reduce the vitreous cytokines levels. Among these drugs, recombinant IL-10, which is still in its experimental phase, might be considered as a new therapeutic agent.


Related Articles

  • The comparison of the impact of ghrelin and tacrolimus on vitreous cytokine levels in an experimental uveitis model. Gül, Fatih; Turgut, Burak; Dağlı, Ferda; İlhan, Nevin; Özgen, Metin // Graefe's Archive of Clinical & Experimental Ophthalmology;Apr2013, Vol. 251 Issue 4, p1235 

    Background: We aimed to compare the effects of intraperitoneal ghrelin and tacrolimus on vitreous levels of tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6) in an experimental autoimmune uveitis model. Methods: Twenty-four male rats, each weighing 300 g,...

  • Amelioration of Experimental Autoimmune Uveitis by Leflunomide in Lewis Rats. Fang, Cheng-bo; Zhou, De-xi; Zhan, Shu-xiang; He, Yong; Lin, Zhen; Huang, Cheng; Li, Jun // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Purpose: To investigate the efficacy of leflunomide in experimental autoimmune uveitis (EAU) in rats. Methods: Lewis rats were immunized with interphotoreceptor retinoid-binding peptide (IRBP) in order to generate EAU. Rats received three dose of leflunomide through intragastric administration...

  • The Potential of Newer Immunomodulating Drugs in the Treatment of Uveitis: A Review. Salzmann, J.; Lightman, S. // BioDrugs;2000, Vol. 13 Issue 6, p397 

    Uveitis, or intraocular inflammation, remains an ongoing challenge to ophthalmologists and patients alike. In most patients, uveitis is limited to the anterior ocular structures and is readily managed with topical steroids. The inflammatory process can extend behind the lens to involve the pars...

  • Inhibition of Experimental Autoimmune Anterior Uveitis by Adenovirus-Mediated Transfer of the Interleukin-10 Gene. I-Mo Fang; Chang-Ping Lin; Chang-Hao Yang; Bor-Luen Chiang; Chung-May Yang; Lee-Young Chau; Muh-Shy Chen // Journal of Ocular Pharmacology & Therapeutics;Dec2005, Vol. 21 Issue 6, p420 

    Aims: The aim of this study was to investigate the efficiency of adenoviral-mediated transfer of the interleukin (IL)-10 gene for inhibition of experimental autoimmune anterior uveitis, a rat model of human acute anterior uveitis. Uveitis was induced in the Lewis rat by simultaneous injection of...

  • Elevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients. Takeuchi, Masaru; Sato, Tomohito; Tanaka, Atsushi; Muraoka, Tadashi; Taguchi, Manzo; Sakurai, Yutaka; Karasawa, Yoko; Ito, Masataka // PLoS ONE;9/9/2015, Vol. 10 Issue 9, p1 

    Macrophages are involved in low-grade inflammation in diabetes, and play pathogenic roles in proliferative diabetic retinopathy (PDR) by producing proinflammatory cytokines. T cells as well as other cells are also activated by proinflammatory cytokines, and infiltration into the vitreous of...

  • Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Takeru Yoshimura; Koh-Hei Sonoda; Nobuyuki Ohguro; Yoshiyuki Ohsugi; Tatsuro Ishibashi; Daniel J. Cua; Takashi Kobayashi; Hiroki Yoshida; Akihiko Yoshimura // Rheumatology;Apr2009, Vol. 48 Issue 4, p347 

    Objectives. Human endogenous uveitis is one of the sight-threatening diseases associated with variety of systemic disorders, such as Behcets disease and sarcoidosis. Recently, biosynthesized antibodies against inflammatory cytokines have been recognized to be useful to control the regional...

  • Measurement of interleukins in vitreous infusion fluid. SATORU KASE; MASAHIKO YOKOI; SUSUMU ISHIDA; MANABU KASE // Biomedical Reports;Nov2015, Vol. 3 Issue 6, p818 

    Measurements of interleukin (IL)-6 and -10 concentrations in the vitreous can be used to differentiate intraocular lymphoma (IOL) from uveitis. This is the first study reporting the IL-6 and -10 concentrations in the undiluted vitreous fluid and vitreous infusion fluid, which were simultaneously...

  • S-nitrosoglutathione Prevents Interphotoreceptor Retinoid-Binding Protein (IRBP161–180)-Induced Experimental Autoimmune Uveitis. Haq, Ehtishamul; Rohrer, Baerbel; Nath, Narender; Crosson, Craig E.; Singh, Inderjit // Journal of Ocular Pharmacology & Therapeutics;Jun2007, Vol. 23 Issue 3, p221 

    Purpose: Experimental autoimmune uveitis (EAU), an animal model of human uveitis, is an organ-specific autoimmune disease mediated by various inflammatory cytokines. In particular, tumor necrosis factor (TNF)- α, interleukin (IL)-1 β and interferon (IFN)- γ are known to play a role in...

  • Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis. Fisson, Sylvain; Ouakrim, Hanane; Touitou, Valérie; Baudet, Sylvie; Ben Abdelwahed, Rym; Donnou, Sabrina; Miloudi, Amine; Galand, Claire; Bodaghi, Bahram; LeHoang, Phuc; Brissard, Martine; Le Garff-Tavernier, Magali; Fridman, Wolf Herman; Sautès-Fridman, Catherine; Cassoux, Nathalie; Merle-Béral, Hélène // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Primary intraocular lymphoma (PIOL), also called primary vitreoretinal lymphomas, often masquerades as uveitis. This misdiagnosis can result in subsequent brain involvement and oculocerebral lymphoma (OCL). In this study, we sought to characterize the helper T-cell type 1 (Th1)/Th2 cytokine...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics